Iron deficiency and other types of anemia in infants and children

American Family Physician

Volumn 93, Issue 4, 2016, Pages 270-278

  Wang, Mary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ASCORBIC ACID; CYANOCOBALAMIN; FERRITIN; FERROUS BISGLYCINATE CHELATE; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; FOLIC ACID; HEMOGLOBIN A2; HEMOGLOBIN F; IRON POLYSACCHARIDE; UNCLASSIFIED DRUG; IRON; VITAMIN B COMPLEX;

ARTICLE; BONE MARROW; BONE MARROW DISEASE; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COGNITION; CONGENITAL MEMBRANOPATHY; CORD CLAMPING; FOLIC ACID DEFICIENCY; GESTATIONAL AGE; HUMAN; HYPOTHYROIDISM; IMMUNE MEDIATED INJURY; INBORN ERROR OF METABOLISM; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON THERAPY; LIVER DISEASE; MACROCYTIC ANEMIA; MASS SCREENING; MATERNAL OUTCOME; MEAN CORPUSCULAR VOLUME; MEDICAL PROCEDURES; MICROCYTIC ANEMIA; NEONATAL OUTCOME; NORMOCHROMIC NORMOCYTIC ANEMIA; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREGNANT WOMAN; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); THALASSEMIA; ANEMIA, IRON-DEFICIENCY; BLOOD; CHILD; DIETARY SUPPLEMENT; FEMALE; INFANT; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PROCEDURES;

ANEMIA, IRON-DEFICIENCY; CHILD; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; IRON; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 84958524405     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. World Health Organization. Worldwide prevalence of anaemia 1993-2005. 2008. http://whqlibdoc.who.int/ publications/2008/978 924 1596 657 eng.pdf. Accessed October 27, 2015.
2. Baker RD, Greer FR; Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010;126(5):1040-1050.
3. Flerlage J, Engorn B, eds. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 20th ed. Philadelphia, Pa.: Saunder/Elsevier; 2015:305.
4. Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98-104.
5. Janus J, Moerschel SK. Evaluation of anemia in children. Am Fam Physician. 2010;81(12):1462-1471.
6. World Health Organization. The global prevalence of anaemia in 2011. http://apps.who.int/iris/ bitstream/10665/177094/1/9789 241 564 960 eng. pdf?ua=1. Accessed November 16, 2015.
7. Dalenius K, Borland E, Smith B, Polhamus B, Grummer- Strawn L. Centers for Disease Control and Prevention. Pediatric Nutrition Surveillance 2010 Report. 2012. http: / /www.cdc.gov/pednss /pdfs /PedNSS_2010_ Summary.pdf. Accessed October 27, 2015.
8. Siu AL; U.S. Preventive Services Task Force. Screening for iron deficiency anemia in young children: USPSTF recommendation statement. Pediatrics. 2015; 136(4):746-752.
9. Biondich PG, Downs SM, Carroll AE, et al. Shortcomings in infant iron deficiency screening methods. Pediatrics. 2006;117(2):290-294.
10. U.S. Preventive Services Task Force. Iron deficiency anemia in young children: screening, September 2015. ht tp: / /www.uspreventiveservicestaskforce.org/ Page/Document/UpdateSummaryFinal/iron- deficiency-anemia-in-young-children-screening?ds=1&s=Iron%20 deficiency%20anemia%20screening%29. Accessed January 11, 2016.
11. Bermejo F, García-López S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol. 2009;15(37):4638-4643.
12. Jain S, Kamat D. Evaluation of microcytic anemia. Clin Pediatr (Phila). 2009;48(1):7-13.
13. Sazawal S, Dhingra U, Dhingra P, et al. Efficiency of red cell distribution width in identification of children aged 1-3 years with iron deficiency anemia against traditional hematological markers. BMC Pediatr. 2014;14:8.
14. Scholl TO. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev. 2011;69 (suppl 1): S23-S29.
15. U.S. Preventive Services Task Force. Iron deficiency anemia in pregnant women: screening and supplementation. September 2015. http://www.uspreventive servicestaskforce.org/Page/Document/UpdateSummaryFinal /iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation?ds=1&s=Iron%20 deficiency%20anemia%20screening%29. Accessed January 11, 2016.
16. Peña-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev. 2009;(4):CD004736.
17. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736.
18. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA. 2007;297(11):1241-1252.
19. Andersson O, Hellström-Westas L, Andersson D, Domellöf M. Effect of delayed versus early umbilical cord clamping on neonatal outcomes and iron status at 4 months: a randomised controlled trial. BMJ. 2011;343:d7157.
20. Rabe H, Diaz-Rossello JL, Duley L, Dowswell T. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2012;(8):CD003248.
21. Andersson O, Domellöf M, Andersson D, Hellström- Westas L. Effect of delayed vs early umbilical cord clamping on iron status and neurodevelopment at age 12 months: a randomized clinical trial. JAMA Pediatr. 2014;168(6):547-554.
22. Uijterschout L, Vloemans J, Rövekamp-Abels L, Feitsma H, van Goudoever JB, Brus F. The influences of factors associated with decreased iron supply to the fetus during pregnancy on iron status in healthy children aged 0.5 to 3 years. J Perinatol. 2014;34(3):229-233.
23. Brotanek JM, Halterman JS, Auinger P, Flores G, Weitzman M. Iron deficiency, prolonged bottle-feeding, and racial/ethnic disparities in young children. Arch Pediatr Adolesc Med. 2005;159(11):1038-1042.
24. Rosado JL, González KE, Caamaño Mdel C, García OP, Preciado R, Odio M. Efficacy of different strategies to treat anemia in children: a randomized clinical trial. Nutr J. 2010;9:40-50.
25. De-Regil LM, Jefferds ME, Sylvetsky AC, Dowswell T. Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database Syst Rev. 2011; (12): CD009085.
26. Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood. Am J Clin Nutr. 2006; 84(6): 1261-1276.
27. Beard JL. Why iron deficiency is important in infant development. J Nutr. 2008;138(12):2534-2536.
28. Domellöf M. Iron requirements in infancy. Ann Nutr Metab. 2011; 59(1): 59-63.
29. Domellöf M, Braegger C, Campoy C, et al.; ESPGHAN Committee on Nutrition. Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr. 2014; 58(1):119-129.
30. Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med. 1991;325(10):687-694.
31. Wang B, Zhan S, Gong T, Lee L. Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev. 2013; (6):CD001444.
32. Abdullah K, Kendzerska T, Shah P, Uleryk E, Parkin PC. Efficacy of oral iron therapy in improving the developmental outcome of pre-school children with non-anaemic iron deficiency: a systematic review. Public Health Nutr. 2013;16(8):1497-1506.
33. McDonagh MS, Blazina I, Dana T, Cantor A, Bougatsos C. Screening and routine supplementation for iron deficiency anemia: a systematic review. Pediatrics. 2015;135(4):723-733.
34. Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339-344.
35. Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2007; 92(2):F83-F88.
36. Christensen RD, Henry E. Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics. 2010;125(1):120-125.
37. Quinn CT. Sickle cell disease in childhood: from newborn screening through transition to adult medical care. Pediatr Clin North Am. 2013; 60(6):1363-1381.
38. Yawn BP, Joylene JS. Management of sickle cell disease: recommendations from the 2014 expert panel report. Am Fam Physician. 2015; 92(12):1069-1076.
39. van den Akker M, Dror Y, Odame I. Transient erythroblastopenia of childhood is an underdiagnosed and self-limiting disease. Acta Paediatr. 2014;103(7):e288-e294.
40. Demir N, Koc A, Üstyol L, Peker E, Abuhandan M. Clinical and neurological findings of severe vitamin B12 deficiency in infancy and importance of early diagnosis and treatment. J Paediatr Child Health. 2013; 49(10):820-824.